All of this is hopeful news, what I wonder is why Low Dose Naltrexone, a drug already out on the market, with a simple action, no lasting side effects and genuine side benefits (and which can be taken in conjunction with other drugs) is not being used as a first line therapy? Like any drug it doesn't work for all, but when it works it changes lives. Is the fact that it's off patent the reason? Is the lack of research on this drug simply due to the fact that high profits cannot be reaped?
The efficacy and safety of LDN is proven, but it's a drug that patients find out about by luck and then have to fight for even a year's trial. Those with IBD have enough to fight, we don't need to fight for a chance to try a medication that has real potential to help us without any lasting risks.
All of this is hopeful news, what I wonder is why Low Dose Naltrexone, a drug already out on the market, with a simple action, no lasting side effects and genuine side benefits (and which can be taken in conjunction with other drugs) is not being used as a first line therapy? Like any drug it doesn't work for all, but when it works it changes lives. Is the fact that it's off patent the reason? Is the lack of research on this drug simply due to the fact that high profits cannot be reaped?
The efficacy and safety of LDN is proven, but it's a drug that patients find out about by luck and then have to fight for even a year's trial. Those with IBD have enough to fight, we don't need to fight for a chance to try a medication that has real potential to help us without any lasting risks.